- Home
- ARQQ vs SIGA Comparison
ARQQ vs SIGA Comparison
Compare ARQQ & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- SIGA
- Stock Information
- Founded
- ARQQ 2017
- SIGA 1995
- Country
- ARQQ United Kingdom
- SIGA United States
- Employees
- ARQQ N/A
- SIGA N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- SIGA Health Care
- Exchange
- ARQQ Nasdaq
- SIGA Nasdaq
- Market Cap
- ARQQ 742.0M
- SIGA 594.3M
- IPO Year
- ARQQ N/A
- SIGA 1997
- Fundamental
- Price
- ARQQ $43.63
- SIGA $8.28
- Analyst Decision
- ARQQ Strong Buy
- SIGA
- Analyst Count
- ARQQ 1
- SIGA 0
- Target Price
- ARQQ $60.00
- SIGA N/A
- AVG Volume (30 Days)
- ARQQ 1.0M
- SIGA 340.6K
- Earning Date
- ARQQ 12-04-2025
- SIGA 11-06-2025
- Dividend Yield
- ARQQ N/A
- SIGA 7.22%
- EPS Growth
- ARQQ N/A
- SIGA N/A
- EPS
- ARQQ 0.48
- SIGA 1.14
- Revenue
- ARQQ $241,000.00
- SIGA $179,639,422.00
- Revenue This Year
- ARQQ $86.94
- SIGA N/A
- Revenue Next Year
- ARQQ $1,017.32
- SIGA $115.06
- P/E Ratio
- ARQQ $102.19
- SIGA $7.27
- Revenue Growth
- ARQQ N/A
- SIGA 3.86
- 52 Week Low
- ARQQ $5.22
- SIGA $4.95
- 52 Week High
- ARQQ $62.00
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- ARQQ 50.41
- SIGA 46.07
- Support Level
- ARQQ $41.50
- SIGA $8.06
- Resistance Level
- ARQQ $49.33
- SIGA $8.54
- Average True Range (ATR)
- ARQQ 5.59
- SIGA 0.25
- MACD
- ARQQ -0.60
- SIGA -0.01
- Stochastic Oscillator
- ARQQ 36.46
- SIGA 51.38
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.